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Abstract
Hepatitis C virus (HCV) exhibits a high level of genetic variability, and variants with reduced susceptibility to antivirals can
occur even before treatment begins. In addition, alcohol decreases efficacy of antiviral therapy and increases sequence
heterogeneity of HCV RNA but how ethanol affects HCV sequence is unknown. Ethanol metabolism and HCV infection
increase the level of reactive species that can alter cell metabolism, modify signaling, and potentially act as mutagen to the
viral RNA. Therefore, we investigated whether ethanol and reactive species affected the basal sequence variability of HCV
RNA in hepatocytes. Human hepatoma cells supporting a continuous replication of genotype 1b HCV RNA (Con1, AJ242652)
were exposed to ethanol, acetaldehyde, hydrogen peroxide, or L-buthionine-S,R-sulfoximine (BSO) that decreases
intracellular glutathione as seen in patients. Then, NS5A region was sequenced and compared with genotype 1b HCV
sequences in the database. Ethanol and BSO elevated nucleotide and amino acid substitution rates of HCV RNA by 4–18
folds within 48 hrs which were accompanied by oxidative RNA damage. Iron chelator and glutathione ester decreased both
RNA damage and mutation rates. Furthermore, infectious HCV and HCV core gene were sufficient to induce oxidative RNA
damage even in the absence of ethanol or BSO. Interestingly, the dn/ds ratio and percentage of sites undergoing positive
selection increased with ethanol and BSO, resulting in an increased detection of NS5A variants with reduced susceptibility to
interferon alpha, cyclosporine, and ribavirin and others implicated in immune tolerance and modulation of viral replication.
Therefore, alcohol is likely to synergize with virus-induced oxidative/nitrosative stress to modulate the basal mutation rate
of HCV. Positive selection induced by alcohol and reactive species may contribute to antiviral resistance.
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Introduction
Hepatitis C virus (HCV) is a major etiologic agent of severe liver
diseases including cirrhosis and hepatocellular carcinoma that has
infected about 170 million people worldwide. Current anti-HCV
therapy, consisting of pegylated interferon alpha and a nucleoside
analog, ribavirin, results in sustained virological response in only
50-60% of patients undergoing treatment [1,2]. Both the efficacy
of antiviral therapy and success of re-treating the resistant
population are strongly affected by HCV sequence. Specific
HCV factors have also been identified that can affect the
sensitivity of the virus to antivirals, such as NS5A [1,2]. In
addition, HCV, like other RNA viruses, exhibits a high level of
genetic variability that complicates antiviral therapy and develop-
ment of vaccines. HCV variants with reduced susceptibility to
antivirals can occur naturally, even before treatment begins [3].
Such pronounced basal sequence heterogeneity and generation of
escape mutants remain an ongoing concern even as new antivirals
and vaccine candidates are being tested [3,4,5]. Furthermore,
alcohol decreases the efficacy of anti-HCV therapy, and alcohol
use is correlated with increased sequence heterogeneity of HCV
RNA in patients [6,7]. However, how ethanol affects HCV
sequences is unclear.
Ethanol metabolism generates acetaldehyde and reactive
oxygen species (ROS), reactive nitrogen species (RNS), and lipid
peroxidation products while decreasing glutathione (GSH) and
selenium [8]. In addition, HCV induces oxidative/nitrosative
stress through several mechanisms which is exacerbated by
ethanol, and GSH is significantly depleted in hepatitis C patients
[8,9]. Acetaldehyde, ROS, RNS, and lipid peroxidation products
can attack the bases and deoxyribose backbone of the DNA and/
or RNA and may thus act as mutagen to the viral RNA [10,11]. In
addition, evolution is affected by the environment, and ethanol,
reactive species, and lipid peroxidation products can also alter the
intracellular milieu for viral replication by modification of cell
metabolism and signaling which may cause the virus to adapt
[12,13].
The goal of this study, therefore, was to test the effects of
ethanol and reactive species on the mutability of HCV RNA in
hepatocytes. Genotype 1 HCV shows higher resistance to therapy.
Thus, Con1 replicon of genotype 1b, which is the best
characterized in terms of adaptive mutations and replicative
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cytotoxic concentrations of ethanol and acetaldehyde and then
analyzed for mutation trends. L-Buthionine-S,R-sulfoximine (BSO)
decreases intracellular GSH by 60–75% in these cells and was also
utilized in the study to test the effects of GSH depletion seen in
hepatitis C patients [14,15]. Exogenous H2O2, on the other hand,
was used to observe the effects of sublethal, exogenous oxidative
stress [16]. We found that ethanol and reactive species increase
oxidative RNA damage and sequence heterogeneity of the HCV
RNA with evidence of positive selection. RNA damage, sequence
heterogeneity of HCV RNA, and positive selection could be
decreased by ROS/RNS-decreasing agents. Mutation trends and
possible biological consequences of these mutations are discussed.
Results
Ethanol and reactive species increase the mutation rate
of HCV
To determine whether ethanol can affect the sequence
variability of HCV RNA, Huh7 cells that support continuous
replication of genotype 1b Con1 replicon RNA were incubated
with ethanol (0.5% v/v), acetaldehyde (10 mM), bolus H2O2
(100 mM), or BSO (20 mM) once daily for 48 hrs [16]. Then, the
RNAs were collected, and the NS5A region was cloned by reverse
transcription-polymerase chain reaction, sequenced, and com-
pared against Con1(S1179I) sequence. We focused on NS5A
because of its moderate level of diversity and its role in viral
replication and antiviral resistance [1,2,17,18]. The T7 HCV
RNA transcript, initially used to generate the replicon cells, was
also sequenced to assess the basal level of RNA heterogeneity
potentially rising from any heterogeneity of HCV DNA used in the
in vitro transcription as well as errors generated during transcrip-
tion and/or cloning. After subtracting the T7 baseline values, the
nt. and amino acid substitution rates of control cells were
determined to be 2.89610
24 nt. changes per site and
2.80610
24 amino acid changes per codon (Table 1). The ethanol
group showed a 6 fold increase in the nt. substitution rate and an
18 fold increase in the amino acid substitution rate over the
control (P,0.001). The BSO group also displayed a significant
increase in the sequence variability of HCV RNA, showing
approximately 4 and 12 fold increases in nt. and amino acid
substitution rates, respectively (P,0.05). H2O2 and acetaldehyde
did not increase the nt. substitution rates significantly (5.28610
24
and 4.25610
24 nt. change per site, respectively, P.0.05) but the
amino acid substitution rate increased by about 10 fold with
H2O2. Therefore, ethanol and conditions that mimic GSH
depletion seen in vivo could increase the nt. and amino acid
substitution rates of HCV RNA over 48 hr.
Analysis of 1,212 genotype 1b sequences in the HCV sequence
database revealed that transitions account for over 83.5% of all nt.
substitutions (Table S1) with the Ts/Tv ratio of 5.05. Likewise,
transitions comprised the majority of the nucleotide substitutions
in our control and treatment groups (Table 1 and Table S1).
Ethanol increased transitions more than transversions such that
the Ts/Tv ratio rose from 3.3 to 6.8.
Ethanol, reactive species, and oxidative RNA damage
The observation that BSO had a greater effect on the HCV
sequence than exogenous H2O2 or acetaldehyde suggested that
there was a substantial level of endogenous oxidative/nitrosative
stress in these cells and that endogenous ROS/RNS may have a
greater effect on the HCV RNA than acetaldehyde. Therefore, to
substantiate the presence of oxidative/nitrosative stress and to test
the potential role of oxidative RNA damage in the accelerated
mutation rate of HCV in ethanol and BSO groups, we measured
8-OHG; 8-OHG is the best-characterized and abundant form of
ROS/RNS-generated RNA species [10,11]. NiCl2, a positive
control mutagen [19], induced a 55.463.1 fold increase in 8-
OHG content over the control (P,0.05) (Fig. 1A). In addition,
ethanol and BSO increased the level of 8-OHG by 34.961.2 and
23.461.5 folds, respectively (P,0.05) (Fig. 1A). Therefore, ethanol
and reactive species could damage the RNA under the same
conditions that elevated the sequence variability of HCV RNA.
Daily treatment of the replicon cells with 0.1% ethanol (v/v) or
20 mM BSO for 2 weeks likewise led to significant increases in 8-
OHG (Fig. 1B). The 0.1% ethanol is equivalent to blood alcohol
concentration of 17.2 mM, which is approximately the legal limit
for driving under the influence in many countries.
Then, whether agents that decrease ROS/RNS can reduce the
accelerated mutation rate of HCV was tested. As HCV infection is
associated with iron overload [8], cells were incubated with a,a’-
dipyridyl, a cell permeable iron chelator, in the presence and
absence of ethanol or BSO. Dipyridyl significantly decreased the
level of 8-OHG in both ethanol and BSO groups (Fig. 2A).
Table 1. Nucleotide and amino acid substitution rates in control and treatment groups
a.
Treatment
Group n
b
Nt. change
per site
c Fold increase
Amino acid
change
per site
d
Fold
increase Ts/Tv dn/ds
Control 21 2.89610
24 - 2.80610
24 - 3.3 0.31
Ethanol 21 1.71610
23
(P,0.001)
e
5.9
(absolute increase
of 1.42610
23)
4.97610
23
(P,0.001)
e
17.8
(absolute increase
of 4.69610
23)
6.8 1.05
BSO 28 1.20610
23
(P,0.001)
e
4.2
(absolute increase
of 0.91610
23)
3.24610
23
(P,0.001)
e
11.6
(absolute increase
of 2.96610
23)
3.3 0.72
aNucleotide and amino acid sequences used in the study were compared against Con1 sequence.
bNumber of sequences analyzed in each group.
cNt. substitution rate is reported as nt. change per site, which was determined as the number of nt. substitutions divided by total number of nucleotides sequenced in
each group. Data were normalized by the T7 baseline value which was 1.27610
23 nt. change per site.
dAmino acid substitution rate is reported as amino acid change per site, which was determined by computing the number of amino acid substitutions divided by total
number of amino acids analyzed in each group. Data were normalized by the T7 baseline which was 1.96610
23 amino acid change per site. Note the total number of
amino acids analyzed is 1/3 of total number of nucleotides sequenced in each group in
c.
eStatistically significant difference from control.
doi:10.1371/journal.pone.0027436.t001
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(Fig. 2A). 8-OHG could also be decreased by other iron chelators
and inhibitors of nitric oxide synthase, flavoproteins, and CYP2E1
(Fig. S1A). Most of all, dipyridyl decreased the nt. substitution
rates of both ethanol and BSO groups so that there was no longer
any significant increase over the control (Fig. 2B). The amino acid
substitution rate was also significantly attenuated by dipyridyl in
these groups (P,0.05) (Fig. 2C). Likewise, GSH ester decreased
both nt. and amino acid substitution rates of ethanol and BSO
treatment groups (Fig. 2B and 2C).
HCV increases ROS/RNS in hepatocytes [8,9]. Thus, we next
examined whether HCV directly induced oxidative RNA damage
in the absence of ethanol and BSO. Huh7 cells were transfected
with JFH1 RNA that produces infectious virus particles and
exposed to 0.5% ethanol (v/v) or 20 mM BSO daily for 48 hrs, or
to 0.1% ethanol (v/v) or 20 mM BSO daily for 2 weeks. HCV
significantly increased 8-OHG at both time points, and this was
exacerbated by ethanol and BSO (Fig. 2D and 2E). Again,
dipyridyl and GSH ester could reduce the ethanol-, BSO-, and
HCV-induced elevations in 8-OHG (Fig. 2E). HCV core gene also
induced a small but statistically significant increase in 8-OHG (Fig.
S1B).
Ethanol and BSO increase the propensity for antiviral
resistance
Previously, we and others demonstrated that ethanol, at the
concentrations used in the present study, potentiates HCV
replication while H2O2, BSO, and lipid peroxidation products
tend to decrease HCV replication [13,16,20,21,22,23,24]. These
findings appeared to contradict the mutagenic effects that ethanol
can have on HCV RNA under the same conditions (Table 1).
Therefore, we next computed the dn/ds ratio to determine
whether sequences were undergoing purifying selection, positive
selection, or remained neutral during treatments. The dn/ds ratio
of our control group was 0.31, and it increased to 1.05 and 0.72 in
the ethanol and BSO groups, respectively (Table 1). Percentage of
sites showing positive selection also increased from 4.25% in
control group to 12.3% in ethanol and BSO groups (Fig. 3A).
Average comparisons of 1,212 genotype 1b sequences in the HCV
database revealed that 19.5% of the NS5A-coding region
experiences positive selection while about 79% undergoes
purifying selection. Dipyridyl and GSH ester could each decrease
the percentage of sites undergoing positive selection (Fig. 3A). In
addition, dipyridyl reduced the dn/ds ratio of the ethanol group
from 1.05 to 0.46 and that of the BSO group from 0.72 to 0.46.
The dn/ds ratio of the ethanol group dropped from 1.05 to 0.43,
BSO group from 0.72 to 0.21, and control group from 0.31 to
0.24, with GSH ester.
Cumulative synonymous and non-synonymous amino acid
mutations were also plotted against codons to determine whether
mutations clustered at any specific loci (Fig. 3B–3D); vertical steps
represent either synonymous or nonsynonymous mutations
occurring at that site. As shown in Fig. 3C and 3D, mutations
clustered in the C-terminal half of NS5A in ethanol and BSO
groups. Sites undergoing positive selection in our study as well as
the genotype 1b HCV sequences in the database are mapped in
Fig. S2, which shows a greater similarity between the database and
our ethanol and BSO treatment groups than between the database
and our control group. More specifically, 36.4% of sites
undergoing positive selection (dn/ds ratio.1) in our treatment
groups were also found to be under positive selection in the
database versus 21.1% in the control group. In addition, 36.8% of
the sites undergoing positive selection in the HCV database
matched sites that underwent positive selection in the ethanol and
BSO treatment groups, compared to only 4.6% for the control
group. The majority of mutations (97.4%) in our study occurred at
sites undergoing positive selection. Synonymous mutations did not
increase in the treatment groups (Fig. 3C – D).
Interestingly, some of the amino acid substitutions found in our
study were previously associated with antiviral resistance (Table 2).
For example, F37L, which enhances the binding of NS5A to 2’,5’-
oligoadenylate synthetase, occurred in our study with a dn/ds ratio
.1 (Fig. 4A). E442G, V279A, F284S, V445A, E442G, V410A,
I302V, and S414P, which confer or otherwise were strongly
associated with increased resistance to interferon, ribavirin,
cyclosporine, and/or Debio 025 could also be identified
Figure 1. Ethanol, BSO, and oxidative RNA damage. (A) Con1 replicon cells were incubated with 0.5% (v/v) ethanol, 20 mM BSO, or 250 mM
NiCl2 daily for 48 hr and analyzed for 8-OHG by ELISA. (B) Con1 replicon cells were incubated with 0.1% (v/v) ethanol, 20 mM BSO, or 50 mM NiCl2 daily
for 2 weeks and analyzed for 8-OHG by ELISA. Data were expressed as fold increase from the controls (0.13460.013 ng/ml for panel A and
0.41860.109 ng/ml for panel B). * Indicates statistically significant difference from controls (n=4 in panel A, n=6 in panel B).
doi:10.1371/journal.pone.0027436.g001
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PLoS ONE | www.plosone.org 3 November 2011 | Volume 6 | Issue 11 | e27436Figure 2. Effects of dipyridyl and GSH ester on the oxidative RNA damage and HCV mutation rate. (A-C) Con1 replicon cells were
incubated with 0.5% ethanol or 20 mM BSO daily for 48 hr610 mM dipyridyl or 2 mM GSH ester and analyzed for 8-OHG by ELISA (A) or sequenced
and analyzed for nucleotide (B) and amino acid substitution rates (C). Data were expressed as fold increase from the control where the control values
were 0.12260.027 ng/ml (n=6) for panel A, 2.8860.77610
-4 nt. changes per site for panel B, and 2.8060.61610
-4 amino acid changes per site for
panel C. Letter a indicates statistically significant difference from no inhibitor control. Letters b and c represent statistically significant change from
ethanol (no inhibitor) and BSO (no inhibitor), respectively. (D–E) Huh7 cells were transfected with JFH1 RNA and incubated with (D) 0.5% (v/v)
ethanol or 20 mM BSO for 48 hrs, or (E) 0.1% (v/v) ethanol or 20 mM BSO65 mM dipyridyl or 1 mM GSH ester daily for 2 weeks. Then, the samples were
analyzed for 8-OHG by ELISA. Data were expressed as fold increase from the control where the control values were 0.10660.012 and 0.29160.054 ng/
ml for the 48 hr and 2 week time points, respectively. Letters a and b indicate statistically significant difference from the –HCV control and +HCV
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and all of the nonsynonymous mutations removing tyrosine in our
study occurred at this position (Y321C), and Y321C increased the
replicative fitness of HCV in the presence of cyclosporine A
(Fig. 4B). Ethanol and reactive species also generated mutations in
the CD8+ T cell-specific epitopes previously associated with
treatment response (Table 2). Other nonsynonymous amino acid
substitutions were found in the binding regions for viral and host
proteins including double-stranded RNA-activated interferon
induced protein kinase and the putative interferon sensitivity
determining regions (ISDR). Four sites within the ISDR which, in
combinations, enhanced HCV RNA replication in the study by
Kohashi et al. had a dn/ds ratio .1 in our study, but no single
sequence had more than two amino acid substitutions within
ISDR [25]. Amino acid substitutions also occurred in the
interferon/ribavirin resistance-determining region (IRRDR) al-
though no single sequence had more than 3 amino acid
substitutions within IRRDR [26].
We also found other amino acid substitutions previously
reported during in vivo infection of chimpanzees as well as some
that may affect the replication rate of HCV (Table 2). Notably,
50.3% of all nonsynonymous mutations in our study either added
or removed serine, threonine, or tyrosine (STY) in the treatment
groups, versus 9.5% in the control group (P,0.05). Unlike
mutations involving threonine which did not show any obvious
clustering, the majority of mutations involving serine in domain 3
tended to remove serine, whereas mutations that generated serine
were more frequent in domains 1 and 2 (Fig. 4C and 4D). Some of
the STY mutations that occurred more frequently and showed
positive selection are listed in Table S2. In comparison, STY
substitutions constituted 40.1% of all amino acid variations in the
genotype 1b NS5A sequences in the database (Fig. S3). S437
control, respectively, and c indicates statistically significant difference from respective no inhibitor controls (control no inhibitor, ethanol no inhibitor,
and BSO no inhibitor) (n=4).
doi:10.1371/journal.pone.0027436.g002
Figure 3. Synonymous and nonsynonymous amino acid substitutions and positive selection in the NS5A coding region. (A)
Percentage of sites undergoing positive selection (dn/ds ratio.1) in control, ethanol, and BSO groups. Letter a indicates statistically significant
difference from no inhibitor control; b indicates statistically significant difference from respective no inhibitor controls (control no inhibitor, ethanol
no inhibitor, and BSO no inhibitor). (B–D ) Cumulative synonymous and non-synonymous mutations in control (B), ethanol (C), and BSO (D) groups
were plotted against codons via SNAP. Numbers represent NS5A codon number.
doi:10.1371/journal.pone.0027436.g003
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coordination motif were not changed.
Discussion
RNA viruses are notorious for pronounced sequence variability
and high mutation rates that complicate antiviral therapy and
development of vaccines. High mutation rate is attributed to the
error-prone viral replicase among other variables. In this study, we
used HCV, an important hepatotropic human pathogen, plus
ethanol, which is often consumed in relatively high quantities and
metabolized to generate reactive species and other reactive
metabolites in the liver, to examine how these factors affect the
genetic variability of an RNA virus. We found that ethanol and
BSO can elevate the basal sequence heterogeneity of HCV RNA
in hepatocytes within 48 hrs. Agents that decreased the RNA
damage could reduce the sequence variability of HCV. Moreover,
infectious JFH1 induced RNA damage even in the absence of
ethanol and under GSH-sufficient condition, and this was
exacerbated by co-incubation with ethanol or BSO. HCV core
has been strongly implicated in oxidative stress, and could induce a
small increase in 8-OHG in the absence of other viral factors (Fig.
S1B). Endogenous sources of ROS/RNS activated by HCV and
HCV core are likely to include the mitochondria, hepatocyte
NAD(P)H oxidases, inducible nitric oxidase synthase, as well as
CYP2E1 [8,9,13]. In addition, effects of iron chelator suggest a
Table 2. Functional changes associated with mutations found in this study
a.
Mutation in
Literature Function
b Occurrences in Study
c dN/dS.1 at codon
d Ref
e
F37L Inhibition of 2’,5’-oligoadenylate synthetase F37L (4) Yes [67]
Y321N Resistance to cyclosporine; conformational
change in a major cyclophilin A binding region
Y321C (4) Yes [68,69]
V279A Resistance to cyclosporine V279A (2) No [70,71]
F284S Resistance to cyclosporine F284S (2), F284L (1) Yes [70,71]
D320E Resistance to cyclosporine D320H (1) No [69,70]
V445A Resistance to Debio 025 V445A (1) Yes [70]
E442G Resistance to IFN E422G (1), E422K (2), E422V (1) Yes [72]
V410A Resistance to IFN V410A (2) Yes [72]
I302V Resistance to IFN I302V (1) Yes [72]
S414P Resistance to IFN S414P (1) No [72]
W433R Resistance to IFN W433S (1), W433C (1) Yes [72]
S390R Resistance to IFN S390N (1) No [72]
K277E Resistance to IFN K277R (1) No [72]
E442G Resistance to ribavirin E442G (1) Yes [40]
G404S Resistance to ribavirin G404D (1) No [40]
T21A Occurred during in vivo infection of chimpanzees T21A (2) Yes [73]
M133V Occurred during in vivo infection of chimpanzees M133V (1) Yes [73]
R318H Occurred during in vivo infection of chimpanzees R318H (1) Yes [73]
N69T Occurred during passage in HEK 293/Sip-L cells N69T (3) Yes [74]
V177I Occurred during passage in HEK 293/Sip-L cells V177I (1) No [74]
N105Y Occurred during passage in HEK 293/Sip-L cells N105S (1), N105D (1), N105G (1) Yes [74]
A211E Occurred during passage in HEK 293/Sip-L cells A211V (1) No [74]
A252V/F Increased HCV replication A252V (3) Yes [25]
T244I Increased HCV replication T244A (2) Yes [25]
H247Y Increased HCV replication H247Y (2) Yes [25]
R246Q Increased HCV replication R246L (1) Yes [25]
K68R Increased HCV replication K68R (2) No [75]
L226S Increased HCV replication L226S (1) No [75]
S264P Increased HCV replication E264G (1) No [75]
M313A Increased HCV replication M313V (1) Yes [76]
G341A Increased HCV replication G341R (1) No [76]
aMutations from literature were aligned to and listed by the codon numbers used in our study.
bFunctions attributed to mutations in the literature.
cAmino acid substitutions occurring at the same position in our study with the number of occurrences shown in parenthesis. Mutations that occurred more frequently
are listed in top rows.
dYes = positive selection occurring in our study; No = no positive selection.
eLiterature describing mutations in column a.
doi:10.1371/journal.pone.0027436.t002
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oxidative RNA damage. These data suggest that HCV genome
variability would be affected by endogenous reactive species and
GSH depletion occurring in vivo, and that reactive species’
accelerating the mutation rate is a direct consequence of HCV
infection. These factors, therefore, likely contributed to previous
estimation of the mutation rate of HCV in patients. In addition,
although the overall quasispecies complexity of HCV is expected
to be much higher in vivo than in our in vitro study that used a single
HCV clone, and the magnitude of increase in sequence variability
caused by alcohol is also likely to be higher in vivo (about 4.5%
increase with alcohol in reference [7]) than our in vitro study that
showed maximal increase in nt. substitution rate of ,0.14% (from
about 0.03 to 0.17% with ethanol, Table 1) and amino acid
substitution rate of ,0.47% (from about 0.03 to 0.5% with
ethanol, Table 1), the effects of ethanol observed in our study may
have contributed to the increased heterogeneity of HCV RNA
reported with alcohol in the studies by Sherman et al. and
Takahashi et al; [6,7]. In fact, positive selection data from the
HCV sequence database were closer to our treatment groups than
the control group (Fig. S2), which is consistent with an important
role of GSH depletion and endogenous and exogenous sources of
reactive species in viral evolution in vivo. Any differences between
our study and the database (Fig. S2) may be attributed to variable
Figure 4. Amino acid substitutions in the NS5A coding region. (A) Structural and functional domains of HCV NS5A [17]. Numbers represent
NS5A condon number. (B) Con1(wt) and Con1(Y321C) replicon cells were treated with 1 mM cyclosporine (CsA) for 48 hrs. Total RNA was extracted
and HCV RNA was determined. * Indicates a statistically significant difference. (C-D) Location of amino acid substitutions involving serines (C),
threonines (D), and tyrosines (D). Putative basal phosphorylation regions are shaded in (A, C, D).
doi:10.1371/journal.pone.0027436.g004
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replicon cell model, diurnal/hormonal/age-dependent fluctua-
tions in GSH, fluctuations in the level of oxidative/nitrosative
stress with viral titer and stage of liver disease, and presence of
additional selection pressures in vivo.
Our data show that prolonged exposure to low level of ethanol
(0.1%, equivalent to 17.2 mM blood alcohol concentration, daily
for 2 weeks) could induce RNA damage, as short-term exposure to
higher concentration of ethanol (0.5% daily for 48 hrs) also did.
Interestingly, prolonged exposure to a low level of ethanol
produced less damage than acute exposure to a higher level of
ethanol, suggesting that cells adapt to or compensate for chronic
repeat exposure to low level of ethanol better than acute exposure
to high levels of ethanol. The 0.1% ethanol is approximately the
legal limit for drinking under influence in many countries
including the U.S.; 0.5% lies in the toxic range but is achieved
physiologically, particularly in chronic alcohol users; ethanol is
also volatile and the amount metabolized by the cell is significantly
less than what is added to cell culture [27]. The concentration of
acetaldehyde used in the study also lies within physiological range
[28]. These concentrations of ethanol and acetaldehyde did not
induce significant cytotoxicity during short-term (48 hr) exposure
[13], but prolonged exposure to 0.5% ethanol was not tolerated
well by the cell and could not be continued for 2 weeks. As 20 mM
BSO is needed in these cells to achieve the level of GSH depletion
seen in hepatitis C patients, the same concentration was used in
both short-term and long-term experiments. It is known that 70 –
80% reduction in GSH is generally well-tolerated by cells, and
BSO did not produce apparent cytotoxicity in our study.
HCV, like other RNA viruses, operates near error threshold
and increasing its mutation rate beyond this threshold can lead to
an error catastrophe [29,30]. In this study, both ethanol and BSO
induced RNA damage but, as mentioned, H2O2 and BSO were
previously found to suppress HCV RNA replication through
calcium modulation whereas the same concentrations of ethanol
elevated HCV replication in these cells and in patients
[13,20,21,23,31,32,33,34,35,36,37,38]. GSH favored HCV repli-
cation by countering the suppressive effects of oxidants [14]. While
these findings are difficult to reconcile and may appear
contradictory, ethanol and oxidative stress/BSO have many
effects on the cell, and recently we showed that these seemingly
opposite effects of acute ROS/BSO vs. ethanol were explained by
other metabolites of ethanol (acetaldehyde, acetate, acetylCoA,
and NADH) that had strong lipogenic and therefore favorable
effects on HCV that replicates in lipid-rich environment [13].
Furthermore, synonymous mutations did not increase while dn/ds
ratio increased with ethanol and BSO treatments in our study.
This indicates that mutations we detected were largely due to
positive selection. Thus, it is possible that disadvantageous
mutations were outcompeted by selection of favorable mutations
as the virus adapted to new environment [39]. Indeed, adaptive
mutations that affect HCV replication could be detected (Table 2)
but nonsense mutations were rare in the study, and it may be
speculated that such viral RNAs were outcompeted or eliminated
by a process like the nonsense-mediated decay. Importantly, it has
also been contested that, under certain conditions, mutagens can
impose selection pressure for the development of resistance
[39,40]. Finally, while ethanol and BSO may affect the replicative
fitness of individual sequence variants (Table 2, Table S2), it
should be noted that frequency of such mutations were still low,
and how some of these mutations modulate NS5A phosphoryla-
tion and/or viral replication remains to be tested systematically
[8,16,17,41]. Thus, overall effects of ethanol and oxidative stress/
BSO on viral replication appears to be more biochemically driven,
such as by elevation of cytosolic calcium and NADH/NAD+ and
cholesterol content, and the significance of increased sequence
heterogeneity may lie in increasing the repertoire of sequence
variants to facilitate viral escape and persistence (e.g., when
subjected to subsequent antiviral therapy), rather than altering the
replicative fitness of HCV genome population as a whole via
mutations.
In addition to overall increases in the mutation rate, specific
NS5A variants previously implicated in antiviral resistance to
interferon, ribavirin, cyclosporine, and Debio 025 could be
demonstrated in the study (Table 2 and Table S2). Although the
frequency of specific mutations was low, these mutations
demonstrate specific changes to the HCV genome that may
predispose HCV to antiviral resistance. In terms of the
mechanism, some of these mutations were most likely generated
randomly but positive selection clearly occurred at many of these
sites (Table 2). The mechanism by which ethanol and BSO
induced positive selection of specific variants remains unknown.
Nonetheless, the data strongly suggest that ethanol, reactive
species, and certain antivirals have some shared effects so that
adaptation to one can affect resistance to another. Here, it may be
noteworthy that H2O2 and BSO have been shown to activate the
Jak/Stat pathway in a ligand-independent manner [42,43].
Mechanism is likely to involve oxidative modification of protein
tyrosine phosphatases and modulation of Jak [44,45]. Ethanol and
reactive species can also modulate kinases that have been
implicated in NS5A phosphorylation as well as antiviral action
of cyclosporine A [12,46,47,48,49,50,51]. In addition to positive
selection, it should also be noted reactive species can directly
modify amino acids, and oxidative stress as well as viral
polymerases can induce transitions or transversions depending
on the types of reactive species and polymerase involved
[52,53,54,55]. Thus, whether the nucleotide substitution trends
purely reflect the most common errors produced by HCV
replicase plus positive selection/chemical mutagenesis of viral
RNA or also other mechanisms, such as direct chemical
modification of the viral replicase by reactive species, remains to
be tested.
Therefore, in this study, we showed that ethanol and
endogenous reactive species can increase the mutation frequency
of HCV in hepatoma cells with evidence of positive selection.
Positive selection induced by ethanol and GSH depletion may
increase the propensity for antiviral resistance. Our data also
suggest that agents that decrease oxidative/nitrosative stress may
help attenuate the basal mutation rate of HCV as well as positive
selection. Clinically, there is increasing evidence that antioxidants
or iron depletion can improve the virological response to IFNa-
based therapy, and it will be important to study these interactions
further using virus-producing systems in vitro as well as in vivo under
both short-term and long-term exposure conditions, with the
inclusion of other regions of HCV genome also implicated in the
antiviral resistance [56,57,58,59,60,61,62,63]. Finally, reactive
species will modify RNAs as well as DNAs, and oxidative/
nitrosative stress is documented in many different virus infections
[64]. Thus, it will be interesting to determine whether some of the
findings of this study also apply to other viruses and their
physicochemical interactions with the environment affecting viral
evolution.
Materials and Methods
HCV constructs and cells
Huh7 human hepatoma cell clones supporting continuous
replication of a subgenomic HCV replicon RNA of genotype 1b
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JFH1 strain (AB047639) that produces infectious virus particles in
cell culture were used [16,65]. Huh7 cells were initially described
by Nakabayashi et al., and our Huh7 cell clone metabolizes ethanol
by CYP2E1 [13,66]. The in vitro transcription, transfection of the
viral RNA, and Huh7 cell culture were performed as described
[16,65].
Sequencing and sequence analysis
Total RNAs were collected using Trizol (Invitrogen). Then, the
NS5A region (nt. 4612–6013 of Con1 replicon) was reverse
transcribed/amplified with AccuScript High Fidelity RT-PCR
System (Agilent; reverse transcription error rate is 1.61610
-7, and
DNA polymerase error rate is 4.3610
29). Primer sequences were
5’-ATCAATCGATTGTCTAGAGCTGAAGAGGCTTCACCA-
G-3’ (reverse) and 5’-GCAATCTTGTACAAGCTTCGCAGCG-
CATGGCGTGAT-3’ (forward). cDNA products were cloned into
pUC19viaHindIIIand XbaIsites(underlined)andsequencedatthe
Joint Genome Institute (Livermore, CA) and University of
California Berkeley Sequencing (Berkeley, CA). Sequences
were aligned against Con1(S1179I) sequence, using BioEdit/
MEGA 4.0 Molecular Evolutionary Genetics Analysis software.
Cumulative synonymous and nonsynonymous mutations and
dn/ds ratio were computed using Synonymous Nonsynon-
ymous Analysis Program (SNAP; www.hcv.lanl.gov). Amino
acid substitution trends were analyzed by position using
MutationCounter, a mutation counting program developed
for this project, and compared with 1,212 genotype 1b NS5A
sequences in the Lawrence Livermore HCV sequence database
(www.hcv.lanl.gov). Sequences harboring gaps, undetermined
nucleotides, or incomplete sequences were removed prior to the
analysis. Sequence data from the Joint Genome Institute and
University of California Berkeley Sequencing yielded same
conclusions.
Determination of 8-hydroxyguanosine (8-OHG)
RNA samples were analyzed for 8-OHG by ELISA. Briefly,
RNA was incubated with 10 U each of DNase I (GE Healthcare),
nuclease P1 (SigmaAldrich or US Biological), and alkaline
phosphatase (Promega) and analyzed for 8-OHG using RNA
Damage Kit (Cell Biolabs, Inc.).
Site-directed mutagenesis
An HCV replicon bearing Y321C was generated by site-
directed mutagenesis using QuikChange II XL Site-Directed
Mutagenesis Kit (Agilent), and sequence was confirmed by DNA
sequencing. Primer sequences were 59-GCACGCCCGGATTG-
CAACCCTCCACTG-39 (forward) and 59-CAGTGGAGGGT-
TGCAATCCGGGCGTGC-39 (reverse).
HCV RNA quantitation
HCV RNA was quantified by quantitative reverse transcriptase
polymerase chain reaction, as described [13,16]. Data were
normalized by glyceraldehyde 3-phosphate dehydrogenase mRNA
content.
Statistics
Data were analyzed using Student’s t test, one-way analysis of
variance, or z-test of proportions using SigmaStat 3.1 (Jandel
Scientific). A p value #0.05 was considered significant.
Supporting Information
Figure S1 RNA damage in Con1 replicon cells and with
HCV core. (A) Con1 replicon cells were incubated with 0.5%
ethanol or 20 mM BSO daily for 48 hr with and without 0.1 mM
1,1,4,7,7-diethylenetriaminepentaacetic acid (DETAPAC, an iron
chelator), 5 mM pyridoxal isonicotinoyl hydrazone (PIH, an iron
chelator), 1 mM N
G-methyl-L-arginine acetate (L-NMA, inhibitor of
nitric oxide synthase), 40 mM diphenylene iodonium (DPI, inhibitor
of flavoproteins such as NAD(P)H oxidases), or 25 mMd i a l l y l
disulfide (DADS, inhibitor of CYP2E1). Then, the samples were
analyzed for 8-OHG by ELISA, as described. Data were expressed as
fold increase from the control where the control value was
0.07660.026 ng/ml. Letter a indicates statistically significant
difference from no inhibitor control, and b indicates statistically
significant difference from respective no inhibitor controls (control no
inhibitor, ethanol no inhibitor, and BSO no inhibitor) (P,0.05;
n=4). All biochemicals were obtained from SigmaAldrich except
PIH, which was synthesized (58–59). (B) Huh7 cells that are
transfected with JFH1 core of genotype 2a, Rcp core of genotype 1a,
or empty plasmid vector alone were analyzed for 8-OHG by ELISA.
* Indicates statistically significant difference from the control.
(TIF)
Figure S2 Sites undergoing positive selection, by group.
(A) Location of sites undergoing positive selection in control,
ethanol, and BSO groups. Grey lines indicate sites undergoing
positive selection that match between this study and the database.
Structural and functional domain map of NS5A is drawn
approximately to scale. (B) Location of sites undergoing positive
selection in control, ethanol, and BSO groups, with and without
dipyridyl or GSH ester, and the HCV database. Grey lines
indicate sites undergoing positive selection that match between this
study and the database.
(TIF)
Figure S3 Position of amino acid variations in the
genotype 1b NS5A sequences from database involving
serines, threonines, and tyrosines.
(TIF)
Table S1 Nucleotide substitution trends in control and
treatment groups.
(DOCX)
Table S2 Frequent mutations involving serine/threo-
nine/tyrosine residues in the NS5A region.
(DOCX)
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